VOESTALPINE ADR 1/5/O.N. (VASS) — Defensive Interval Ratio

Latest as of December 2025: 108 days

VOESTALPINE ADR 1/5/O.N. (VASS) has a Defensive Interval Ratio of 108 days as of December 2025. Defensive assets of €1.58 Billion (cash €-, short-term investments €103.70 Million, receivables €1.48 Billion) cover 108 days of daily cash needs of €14.61 Million/day. See VOESTALPINE ADR 1/5/O.N. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

108 days
Days of operational coverage

Defensive Assets

€1.58 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€14.61 Million
Current Liabilities ÷ 365

Current Liabilities

€5.33 Billion
EUR

VOESTALPINE ADR 1/5/O.N. Defensive Interval Ratio (2022–2025)

This chart shows how VOESTALPINE ADR 1/5/O.N.'s Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 108 days, meaning defensive assets of €1.58 Billion can fund 108 days of operations without new revenue. See VOESTALPINE ADR 1/5/O.N. balance sheet quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for VOESTALPINE ADR 1/5/O.N. (2022–2025)

The table below presents the year-by-year Defensive Interval Ratio for VOESTALPINE ADR 1/5/O.N. from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see VASS company net worth.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 86 days €1.25 Billion €14.53 Million/day €- €304.40 Million ▲ +13 days
2024 73 days €1.30 Billion €17.81 Million/day €- €158.20 Million ▼ -17 days
2023 90 days €1.48 Billion €16.37 Million/day €- €341.30 Million ▼ -55 days
2022 145 days €2.40 Billion €16.55 Million/day €- €145.60 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)